Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis

Recruiting Phase 1 Phase 2 Interventional Study
Acute Respiratory Distress Syndrome
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 and older
Sex
Any
Trial phase
Phase 1/2
Study type
Interventional
Purpose
Treatment
Participants needed
15 (estimated)
Sponsor
PT. Prodia Stem Cell Indonesia · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study was conducted to determine the effect of Umbilical Cord Mesenchymal Stem Cell (UC-MSC) and Secretome in severe ARDS patients. The study is a randomized control trial - double blind, which has 3 arms intervention namely, Control treatment, UC-MSC treatment, and UC-MSC and Secretome treatment.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Male or female at least 40 years old when the Informed Consent Form (ICF) is signed by the family, as evidenced by an identity card. * Patients with severe ARDS according to Berlin criteria * Families are willing to participate in clinical trial procedures including not partic…
Contacts

Dewiyana Andari Kusmana

+6281290885529

dewiyana.ku@gmail.com

CONTACT

Cynthia R Retna Sartika, Dr

+62811155048

c.sartika@gmail.com

CONTACT